US-guided RFA vs MWA in the Treatment of Benign Thyroid Nodules (NCT05758038) | Clinical Trial Compass
UnknownNot Applicable
US-guided RFA vs MWA in the Treatment of Benign Thyroid Nodules
50 participantsStarted 2023-03-01
Plain-language summary
To evaluate the clinical outcomes of RFA and MWA for benign thyroid nodules treatment
Who can participate
Age range80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Solid or mixed nodules with predominant solid component with benign pathological result from US guided fine needle aspiration (FNAC).
* Symptomatic and/or cosmetic problems.
* Clinical thyrotoxicosis and hyperthyroidism caused by autonomously functioning thyroid nodules (AFTNs)
* Refusal or ineligible for surgery.
* Anxiety about a malignant transformation.
Exclusion Criteria:
* Malignant nodules on US.
* Cytological evidence for malignancy
* Patients with abnormal coagulation profile.
* previous surgery or medicine for the thyroid, and vocal cord palsy in the side contralateral to the target nodules.